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ABSTRACT
Summary: Copy number variants (CNVs) contribute substantially to
human genomic diversity, and development of accurate and efﬁcient
methods for CNV genotyping is a central problem in exploring
human genotype–phenotype associations. SCIMMkit provides a
robust, integrated implementation of three previously validated
algorithms [SCIMM (SNP-Conditional Mixture Modeling), SCIMM-
SearchandSCOUT(SNP-ConditionalOUTlierdetection)]fortargeted
interrogation of CNVs using Illumina Inﬁnium II and GoldenGate SNP
assays. SCIMMkit is applicable to standardized genome-wide SNP
arrays and customized multiplexed SNP panels, providing economy,
efﬁciency and ﬂexibility in experimental design.
Availability: Source code and documentation are available for
noncommercial use at http://droog.gs.washington.edu/scimmkit.
Contact: troyz@u.washington.edu
Supplementary information: Supplementary data are available at
Bioinformatics online.
1 INTRODUCTION
Copy number variation (CNV) in the human genome contributes
substantially to genomic diversity and disease etiology (Lupski,
2009; McCarroll, 2008). Use of genome-wide SNP genotype data
to perform ab initio discovery of individual CNVs has provided
valuable insight into the spectrum of human genomic variation
(Itsara et al., 2009; Redon et al., 2006). However, with the
development of larger catalogs of common variation (Kidd et al.,
2008; McCarroll et al., 2008) and continuing discovery of rare
variants with severe phenotypic effects (Sebat et al., 2008; Walsh
et al., 2008), it is critical to efﬁciently genotype speciﬁc CNVs in
largepopulations.Targeteddetectionstrategiesgenerallyoutperform
ab initio detection strategies for this task (McCarroll, 2008).
Therefore, we have developed SCIMMkit, a toolkit for targeted
genotyping of CNVs using Illumina Inﬁnium II and GoldenGate
SNP assays.
SNP assays typically generate two measurements per site
(‘A’ and ‘B’ allele ﬂuorescence) forming the canonical genotype
clusters ‘A/A’, ‘A/B’ and ‘B/B’ when visualized by scatterplot.
Deletions of sequence result in decreased signal intensity (i.e. states
‘A/–’, ‘B/–’, ‘–/–’) (Fig. 1), and duplications result in increased
signal intensity (i.e. states ‘AAA’ and ‘BBB’) and aberrant allelic
ratio (i.e. states ‘AAB’and ‘ABB’) (Supplementary Fig. S1). States
corresponding to individual CNVs often fail to form distinct clusters
∗To whom correspondence should be addressed.
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Fig. 1. Fluorescence data for 125 HapMap samples (Cooper et al., 2008) at
a single SNP probe (rs12098109) within a common deletion polymorphism
identiﬁed as a susceptibility factor for psoriasis (de Cid et al., 2009). Copy
number genotypes (blue diamonds, 0; red triangles, 1; black circles, 2) were
computedbySCIMMusingthreeSNPprobes;superimposedcurvesdescribe
components of the estimated mixture distribution.
due to dynamic range limitations; therefore, methods using multiple
SNP probes per site are required for robust copy number inference
(Cooper et al., 2008; Korn et al., 2008; Mefford et al., 2009).
2 DESCRIPTION OF FUNCTIONALITY
SCIMMkit provides three tools for targeted interrogation of CNVs,
each of which assumes prior knowledge of the approximate location
of each interrogated variant: SCIMM (SNP-Conditional Mixture
Modeling), for genotyping polymorphic deletions (frequency
exceeding 1%); SCIMM-Search, for automatically generating
informative probe sets to be used by SCIMM; and SCOUT (SNP-
Conditional OUTlier detection), for detecting rare deletion and
duplication variants (frequency <1%). Each of these tools uses a
statistical model of observed ﬂuorescence data which contains, for
each SNPprobe, separate location parameters for each homozygous
allelic state (i.e. ‘A/A’, ‘A/–’, ‘B/B’, ‘B/–’) and a single dispersion
parameter shared by all homozygous allelic states.
© The Author(s) 2009. Published by Oxford University Press.
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SCIMM assigns diallelic insertion/deletion genotypes (i.e. copy
number ‘0’, ‘1’ and ‘2’), using SNP calls and normalized
ﬂuorescence measurements for a set of n SNP probes hybridizing
speciﬁcally to sequence spanning the deleted region (Cooper et al.,
2008). Two rounds of mixture likelihood-based clustering are used:
the ﬁrst round uses intensity data to call samples near the origin as
‘0’, and the second round uses intensity data and supplied SNP
genotypes to call remaining samples as ‘1’ or ‘2’, using a two-
component, 2n-variate lognormal mixture model. Copy number for
each sample is assumed to be constant for all probes in a set;
accordingly, samples that are SNP heterozygous at any probe are
assumed to have copy number 2 for the purposes of model ﬁtting
and copy number assignment. These statistical assumptions do not
hold for SNPprobes that hybridize non-speciﬁcally (Supplementary
Fig.S2);suchprobesarerejectedduringprobesetgeneration,below.
SCIMM also generates a score for the probe set, deﬁned as the
difference of the Bayesian information criterion (BIC) value for
the two-component model and the BIC value for the corresponding
one-component model. Genotypes are reported only for sites with
positive scores.
SCIMM-Searchcanbeusedtoautomaticallygenerateinformative
probe sets in circumstances where the speciﬁcity assumptions of
SCIMM may not be satisﬁed for all probes in the putatively deleted
region. SCIMM-Search uses the BIC to select between alternate
probe sets, and allows the investigator to specify constraints on
consistency with reference genotypes, internal consistency of the
probe set, probe spacing and dynamic range (Cooper et al., 2008).
SCOUT detects rare deletions and duplications at each targeted
site by initially calculating per-probe scores for each sample, using
a one-component SCIMM model extended to describe ﬂuorescence
data for SNP heterozygotes (Mefford et al., 2009). For SNP
homozygotes, per-probe score is determined solely by intensity;
for SNP heterozygotes, per-probe score is determined by intensity
and deviation from 1:1 allelic ratio (speciﬁcally, by distance of the
observed datum from the line connecting the origin to the center
of the heterozygote cluster). Per-probe scores are approximately
normally distributed, with samples at the center of each canonical
SNPgenotypeclusterreceivingascoreofzero.Theper-probescores
are combined additively to obtain per-site scores, which are then
compared with an empirically determined threshold to generate
a list of putative deletion and duplication events. Hemizygous
and duplicated haplotypes for strongly scoring events are also
reported, allowing inference of complex allelic states (e.g. ‘AAB’,
SupplementaryFig.S1)andparentalchromosomeoforigin(incases
where parental data are available). SCIMMkit also implements an
initial SCOUT quality-control pass which rejects samples with a
genome-wide excess of extreme per-probe scores, improving the
positive predictive value of the per-site SCOUT scores generated
for the remaining samples (Supplementary Fig. S1).
SCIMMkit requires as input a target ﬁle and one or more data
ﬁles. Each line of the target ﬁle speciﬁes a set of probes (with probe
ID and coordinates) and an action associated with the probe set
(i.e. SCIMM genotyping, SCIMM-Search probe set generation or
SCOUTscoring).InputissuppliedinIlluminaBeadStudiogenotype
report format (or similar tabular format).
SCIMMkitgeneratestwoprimaryoutputﬁles:acomma-delimited
matrix with scores and numeric genotype codes (one row per sample
and one column per target site), and a comma-delimited table with
per-site summary information including genotype counts, probe
set scores and SCIMM-Search generated probe sets. SCIMMkit
can optionally generate scatterplots with superimposed SCIMM
genotypes and mixture distribution curves in postscript format.
SCIMMkit is implemented in PERL (used for command-line
interpretation, input parsing and data consolidation) and R (used
for numerically intensive tasks), and has been tested on Apple
Macintosh OS X, Linux and Microsoft Windows platforms.
3 DISCUSSION
SCIMM and SCOUT use a common statistical model to facilitate
distinct applications. SCIMM genotypes polymorphic deletions by
estimating the location of each genotype cluster (‘–/–’, ‘A/–’, ‘B/–’,
‘A/A’, ‘A/B’, ‘B/B’). SCOUT detects rare deletion and duplication
variants by analyzing the location of each sample relative to the
canonical SNP genotype clusters (‘A/A’, ‘A/B’, ‘B/B’), avoiding
estimation of location parameters for rare allelic states (e.g. deletion
states ‘A/–’, ‘B/–’ and duplication states ‘AAB’, ‘ABB’).
SNP-based genome-wide association studies have generated a
wealth of resources for retrospective analysis of CNV (Itsara et al.
2009). The ﬁrst step in analyzing polymorphic variation in such
data is identiﬁcation of CNVs that can be accurately genotyped.
To generate a database of polymorphic deletion sites and validated
copy number-informative probe sets, we used SCIMM-Search to
analyze data generated by the Illumina 1M-DuoV3 array for 269
HapMap samples. We compared the resulting SCIMM-generated
diallelic deletion genotypes with previously published genotypes
generated by BirdSuite software using the Affymetrix SNP 6.0
array (McCarroll et al., 2008). SCIMM produced diallelic deletion
genotypes for 113 common (sample allele frequency at least 5%)
autosomal deletions (84% of which have per-site concordance
to BirdSuite genotypes exceeding 99%), 392 autosomal deletions
of lower frequency (88.5% of which have genotype concordance
exceeding 99% and positive predictive value for deletion status
exceeding 80%) and 6 X-linked diallelic deletions (all of which
have concordance exceeding 98.5%). These concordance rates
are consistent with earlier analyses using independently generated
referencegenotypes(Cooperetal.,2008).Theresultinglistofhighly
concordant sites and corresponding Illumina 1M-DuoV3 probe sets
produced by SCIMM-Search are provided on the SCIMMkit web
site for genotyping polymorphic deletions in other genome-wide
datasets. (See Supplementary Material for details).
Detection of highly pathogenic CNVs presents a distinct
challenge: individually, such variants tend to be rare (frequency
<1%) in affected individuals and very rare or completely absent
in control populations; thus, deﬁnitively establishing a difference
in allele frequency between cases and controls requires analysis
of a large number (many thousands) of samples (International
Schizophrenia Consortium, 2009). To assess the feasibility of
large-scale targeted detection studies, SCOUT was recently used
in conjunction with a customized Illumina BeadXpress assay to
genotype deletions and duplications at 69 non-allelic homologous
recombination hotspots in 1005 individuals with unexplained
intellectual disability (ID). SCOUT correctly detected 48 rare
deletion and duplication events, including 22 events known to
be pathogenic, with only seven false positives (score threshold
|6|, events validated by oligo-array CGH) (Mefford et al., 2009).
Although, SCOUT does not explicitly include batch effects in its
statistical model, the robustness of its model-ﬁtting procedure at
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small sample sizes allows known batch effects to be remedied
by independent scoring of batches. In the ID study above, each
96-well plate was analyzed independently to provide robustness
against plate-to-plate variation in signal intensity and dynamic
range.
We anticipate that future studies of association between CNV
and phenotype will follow a model similar to SNP-based studies:
an ab initio discovery stage (often in a population enriched for the
phenotypeofinterest),aninitialphenotypicassociationtestingstage
and a validation stage where the strongest associations are tested in
a much larger population. SCIMMkit allows efﬁcient and accurate
detection of CNVs in the latter two stages of this model, facilitating
further exploration of the link between CNV and human phenotypic
variation.
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